Beijing, China

Minyi Zhou


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):

Title: Innovations of Minyi Zhou in Interferon Alpha Mutants

Introduction

Minyi Zhou is a distinguished inventor based in Beijing, China, known for his groundbreaking work in the field of biotechnology. With two patents to his name, Zhou's research focuses on improving antiviral therapies through innovative modifications of interferon alpha.

Latest Patents

Zhou's most recent patents involve the development of interferon alpha mutants and their polyethylene glycol derivatives. These IFN-alpha mutants are engineered through the substitution of cysteine for tyrosine at positions 85 or 86 in existing interferon alpha. The resulting polyethylene glycol derivatives showcase high antiviral activity in vitro and an extended half-life in vivo. The covalent bonding of a polyethylene glycol moiety to the free cysteine residue of the IFN-alpha mutant enhances its therapeutic effectiveness. Results from tests indicate that these mutants are readily prepared and exhibit significant activity, while their polyethylene glycol derivatives demonstrate an extended presence in the body with a notably low clearance rate.

Career Highlights

Throughout his career, Minyi Zhou has significantly contributed to various organizations focused on genetic engineering and biotechnology. Notable companies he has been affiliated with include Beijing Tri-prime Genetic Engineering Co., Ltd. and Beijing Bio-tech Development Co., Ltd. His efforts in these establishments have played a crucial role in pushing forward the boundaries of medical science and therapeutic applications.

Collaborations

Zhou has worked alongside prominent colleagues such as Jinyi Liu and Xiaoxia Niu. Their collaborations have fostered an environment of innovative research and development, further enhancing the potential applications of their discoveries in the field of antiviral treatment.

Conclusion

Minyi Zhou's contributions to the field of biotechnology, particularly through his work on interferon alpha mutants, are indicative of his role as a leading inventor in modern medical science. His patents reflect a commitment to advancing antiviral therapies and improving patient outcomes through innovative approaches. The implications of his work continue to drive research and inspire future innovations within the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…